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Abstract
Most studies of smoking and pancreatic cancer have used
male subjects or combined men and women together in
statistical analyses. There is little information on the
relative risk of smoking and pancreatic cancer in women.
Because of the high case-fatality rate, many of these
studies were also based on information gathered from
proxy respondents, in which smoking habits may not be
recalled with certainty. A hospital-based study of 484
male and female patients with pancreatic cancer and 954
control subjects was conducted based on direct interviews
of incident cases. Compared to never smokers, the odds
ratio (OR) for current cigarette smokers was 1.6 [95%
confidence interval (CI), 1.1-2.41 for men and 2.3 (95%
CI, 1.4-3.5) for women. In women, but not in men, there
was a trend in the ORs with years of daily cigarette
consumption (P < 0.01). Filter cigarettes offered no
protective advantage compared to nonfilter cigarettes.
Among men, the OR was 2.1 (95% CI, 1.2-3.8) for pipe/
cigar smokers and 3.6 (95% CI, 1.0-12.8) for tobacco
chewers. Tobacco smoke causes pancreatic cancer when
inhaled into the lungs. Tobacco juice may also cause
pancreatic cancer when ingested or absorbed through the
oral cavity. These data suggest that smoking is a cause of
pancreatic cancer in women and that the risks for female
smokers are comparable to male smokers. Nevertheless,
the causes of most pancreatic cancers are unknown.
Introduction
The pathogenesis of pancreatic carcinoma is not well under-
stood. Only cigarette smoking has been consistently reported as
a risk factor. although its effects are relatively weak. Although
fllOst studies of smoking and pancreas cancer found approxi-
mately 1 .5-2-fold increased risks ( 1-24), other reports found no
effect (25, 26). With few exceptions, the effects of cigarette
smoking have not been examined separately by gender. Be-
cause pancreas cancer is a relatively rare disease, risk estimates
have usually been based on male subjects or on male and
female subjects combined. We examined the effects of cigarette
smoking on pancreatic cancer using a large case-control study
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based on direct interviews. The effects of pipes, cigars, and
smokeless tobacco are also examined.
Materials and Methods
Because of the high case-fatality rate, many case-control stud-
ies of pancreatic cancer obtained exposure information from the
next-of-kin. Furthermore, the response rates from population-
based case-control studies in general are usually lower than
those from hospital-based studies. To minimize potential infor-
mation and selection biases, a hospital-based study of pancre-
atic cancer (International Classification of Disease Codes, 9th
Revision, code 157.0) was conducted in New York City and
other locations (see “Acknowledgments”) that obtained expo-
sure information directly from patients. Daily hospital admis-
sion logs were screened to ascertain newly diagnosed incident
cases of pancreatic cancer who were between the ages of 2 1 and
80. The pathology report of each clinically diagnosed case was
examined to confirm the admitting diagnosis, and only subjects
with a histological confirmation were eligible for entry into the
study. Four hundred and eighty-four patients with pancreatic
carcinoma and 954 control subjects were interviewed between
1985 and 1993 by trained interviewers. Controls were patients
who did not have pancreatic cancer and were hospitalized for
conditions unrelated to tobacco use. Among men, the control
diagnoses were: cancer (soft tissue, melanoma, lymphoma, and
leukemia), 34.8%; musculoskeletal conditions, 9.3%; benign
prostatic hypertrophy, 12.6%; other benign conditions, 6.6%:
injuries/fractures, 7%; and all other diagnoses (nonmalignant
diseases of the nervous system, urinary conditions, skin disor-
ders, ill-defined symptoms, congenital disorders, and others),
29.7%. Among women, the control diagnoses were: cancer
(soft tissue, melanoma, lymphoma, and leukemia), 27.7C/e: be-
nign tumors, 8.9%; musculoskeletal conditions, 16.4%; inju-
ries/fractures, I 2%; and all other conditions (pelvic disorders,
benign breast disease, skin conditions, urinary disorders, and
others), 35%. The control subjects were matched to cases by
hospital, sex, age ( ± 5 years), race, and year of diagnosis. Two
controls were selected for each case. Of the 949 eligible cases
who were approached, 10 (1%) had died, and 373 (39.3%) were
either too ill or unable to communicate, 15 ( I .6%) were phy-
sician refusals, and 67 were patient refusals (7.1%). Control
selection was accomplished by approaching the first eligible
patient fitting the study needs listed on the daily hospital
admission sheets. In case of refusal, the patient with the next
sequential admission on the daily admission sheets with an
acceptable diagnosis was approached. Of the 1526 eligible
controls who were approached, 357 (23.3%) were either too ill
or unable to communicate, 6 (0.4%) had died, I 22 (8.0%) were
physician refusals, and 87 (5.7%) were patient refusals. Written
informed consent was obtained from all patients. The question-
naire included detailed sections on demographics, tobacco
smoking, alcohol consumption, occupation and occupational
exposures, weight, height, and medical history of illness and
disease.
Current smoking was defined as having smoked at least
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Table I Sociodemographic characteristics of pancreatic cancer cases and
controls, 1985-1993
Males Females
Cases Controls Cases Controls
(N = 290 (N = 572) (N = 194) (N = 382)
C/ (7 #{231}f k
Age
<45 7.3 8.0 4.6 7.1
45-54 17.9 18.4 15.5 14.7
55-64 36.2 37.4 33.0 36.7
65-74 32.1 29.6 36.6 34.3
75+ 6.5 6.6 10.3 7.3
Years of education
<12 17.2 15.9 16.5 21.5
12 26.9 24.3 39.2 35.4
13-15 l9.t) 19.1 25.8 21.5
16+ 36.9 40.7 18.6 21.5
Race
White 94.8 95.6 90.2 91.1
Black 4.5 4.0 9.3 8.6
Other 0.7 0.3 0.5 0.3
Religion
Protestant 22.4 26.8 31.4 31.2
Catholic 48.6 47.7 39.2 45.3
Jewish 24.8 23.8 26.8 22.0
Other/None 4.0 4.0 2.6 1.5
one cigarette/day in the year preceding the current diagnosis.
Ex-smokers were quitters who had not smoked within the past
year. Descriptive statistical methods included frequency tables
and  analysis. ORs3 from multiple logistic regression coef-
ficients and 95% CIs were obtained after adjustment for age and
education. The effects of possible confounders including alco-
hol consumption, body weight, and diabetes were assessed by
changes in deviance in the models. The fit of the model was
evaluated by the Hosmer and Lemeshow test (27). All trend
tests were performed by treating the main effect as continuous
response variables and assigning the median value to each
category of exposure.
Results
Information on the site of the cancer in the pancreas was
available for 23 1 (48%) patients. The distribution of the tumor
site was: head, 83%; body, 13%: and tail, 4%. The male:female
ratio of case subjects was I .5. There were little differences in
age, race, and religious status between cases and control pa-
tients (Table 1). The mean age was 61 for male cases, 60 for
male controls, and 62 for both female cases and controls. The
average number of years of education was 14 for both male
cases and controls and I 3 for both female cases and controls.
Twenty-nine percent of male cases and 22% of male
controls were current cigarette smokers. In women, 28% of
cases and 19% of controls were current smokers. The age-
adjusted OR for pancreatic cancer among current smokers was
1.6 (95% CI, 1.1-2.4) for men and 2.3 (95% CI, 1.4-3.5) for
women compared to men and women who never smoked to-
bacco, respectively (Table 2). In the subgroup of case patients
with cancer in the pancreas head, the adjusted OR was 1 .9 (95%
, The abbreviations used are: OR. odds ratio: CI. confidence interval: TSNA,
tobacco-specific N-nitrosamines: NNK. 4.(methylnitrosamino). I -(3-pyridyl)- I.
hutanone: NNAL. 4-(methylnitrosamino). I -(3-pyridyl)- I -butanol.
CI, 1.1-3.3) in men and 1.6 (95% CI, 0.9-3.0) in women. In
patients with cancer in the body, tail, or pancreatic duct, the OR
was 1.2 (95% CI, 0.4-3.2) in men and 4.8 (95% CI, 1.4-16.2)
in women. Among all patients who currently smoked cigarettes,
the risk increased with the number of cigarettes smoked per
day. The OR for smokers of 20-39 cigarettes/day was I .4 (95%
CI, 0.7-2.8) in men and 2.3 (95% CI, 0.8-6.3) in women. For
2 or more packs/day, the OR was 1.8 (95% CI, 0.9-3.6) in men
and 5.6 (95% CI, 2.0-15.8) in women.
In ex-smokers, there was no increased risk among men,
whereas the OR for women was I .9 (95% CI, I .3-2.9). The OR
for men and women who quit within 2 years was actually higher
than for current smokers, especially in women. The risk esti-
mates were 1.7 (95% CI, 0.8-3.7) in men and 10.6 (95% CI,
2.9-39.2) in women; these findings could reflect that some
patients quit smoking with the onset of clinical symptoms. In
the subgroup of patients with cancer in the head of the pancreas,
the OR in quitters was 1.0 (95% CI, 0.6-1.8) in men and 1.4
(95% CI, 0.7-2.5) in women. In patients with cancer in the
body, tail, or pancreatic duct, the OR was 0.7 (95% CI, 0.3-I .8)
in men and 3.2 (95% CI, 1.0-10.6) in women.
When examining the risk by duration, there was a signif-
icant trend with increasing number of years of smoking in
women but not in men. The risk estimates were higher for
women than for men in each duration category of smoking
(Table 2). Male patients who smoked 40 or more years had a
1.3 (95% CI, 0.8 -2.1)-fold risk of pancreatic cancer, compared
to a 2. 1 (95% CI 1 .3-3.4)-fold risk for women. The OR for
smoking nonfilter cigarettes compared to filter cigarettes was
0.7 (95% CI, 0.3-1.9) for men and 1.5 (95% CI, 0.3-8.9) for
women.
Among men, the adjusted OR was 1.8 (95% CI, 0.9-5.3)
for smoking pipes only compared to both never and long-term
quitters (>20 years) combined. The average number of pipes
smoked per day was 6.3 for cases and 6.7 for controls. There
was no trend in the OR with the duration of pipe smoking
(Table 3). The OR for smoking cigars only was 3. 1 (95% CI,
1 .4-6.9) compared to never and former cigarette smokers. The
mean number of cigars smoked per day was 4 for cases and 3
for controls. There was no trend in the ORs with duration of
smoking cigars. There were six male cases and five male
controls who chewed tobacco regularly for at least I year and
did not currently smoke cigarettes. The crude OR for these
tobacco chewers compared to never and long-term quitters was
3.6 (95% CI, 1.0-12.8). There were no women who reported
chewing tobacco or smoking pipes and cigars. Only two male
cases and three male controls reported using snuff for at least I
year.
Discussion
The male:female ratio of 1.5: 1 in white subjects in this study is
similar to the rate ratio in the United States as well as in most
other Western and Asian countries, suggesting a common eti-
ology in many populations. Cigarette smoking has been iden-
tified as a cause of pancreas cancer in most epidemiological
studies of pancreatic carcinoma, although few studies reported
specific risk estimates for women. Because pancreatic cancer is
relatively uncommon, most studies have been based only on
male subjects or have combined men and women in statistical
analyses. Our data indicate that smoking is a cause of pancreatic
cancer in women and that the risks in women are somewhat
higher than in men for categories of amount and duration of
smoking. Somewhat similar findings were observed in another
large population-based study based on direct interviews. In an
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(N = 290) (N = 572) CI) (N 194) (N = 382) (95% CI)
Tobacco smoking
Never 66 157 1 .0 78 22 1 I .0
Current smokers 85 127 1 .6 ( I . 1-2.4) 54 73 2.3 ( I .4-3.5)
Ex-smoker I 14 260 1.0(0.7-1.5) 62 88 1.9 (1.3-2.9)
Pipe/cigar 25 28 2.1 (1.2-3.8) 0.0 0.0
Cigarettes smoked/day
(current smokers)
0 66 157 1.0 78 221 1.0
1-19 48 73 1.5 (0.9-2.4) 37 55 2.1 (1.3-3.6)
20-39 16 27 1.4 (0.7-2.8) 7 1 1 2.3 (0.8-6.3)
40+ 21 27 1.8(0.9-3.6) 10 7 5.6(2.0-15.8)
Smoking yrs
0 66 157 1.0 78 221 1.0
1-9 15 47 0.8 (0.4-1.5) 6 13 1.3 (0.5-3.6)
10-19 27 62 1.0 (0.6-1.8) 1 1 20 1.7(0.8-3.7)
20-29 45 85 1 .3 (0.8-2.0) 26 33 2.4 ( I .3-4.4)
30-39 58 98 1 .4 (0.9-2.2) 38 49 2.2 ( 1.4-3.7)
40 54 95 1 .3 (0.8-2. 1 ) 35 46 2. 1 ( I .3-3.4)
P for trend <0.14 <0.01
Yrs since quitting
(ex-smokers)
0 66 157 1.0 78 221 1.0
1-2 12 17 1.7(0.8-3.7) II 3 10.6(2.9-39.2)
3-5 7 35 0.5 (0.2-1.1) 8 15 1.5 (0.6-3.7)
6-10 15 31 1.2 (0.6-2.3) 12 17 2.1 (0.9-4.5)
>10 80 177 1.1 (0.7-1.6) 31 53 1.6(1.0-2.7)
P for trend NS <0.05
Cigarette filter status”
(current smokers)
Filteronly 23 28 1.0 18 27 1.0
Filter 20 yrs 32 53 0.7(0.3-1.3) 21 31 0.6 (0.3-1.7)
Filter 1-19 yrs 17 28 0.8 (0.3-1.4) 1 1 1 1 1.1 (0.4-3.3)
Nontilter only 10 15 0.7 (0.3-1.9) 4 3 1.5 (0.3-8.9)
“ All ORs were adjusted for age and education. Terms for alcohol were statistically significant in the model examining duration of smoking in men. NS, not significant.
S ORs were also adjusted for cigarettes/thy. Information on filter status was missing for six men and one woman.
analysis of 526 cases and 2 153 controls, Silverman et a!. (23)
found a higher relative risk for women than for men in subjects
who smoked 20 or more years (OR 2. 1 for women, 1 .7 for
men). Also similar to our findings, this group observed a
dose-dependent effect of smoking and a reduced risk associated
with smoking cessation. Using mostly next-of-kin interviews
from 490 pancreatic cancer patients and controls, Mack et a!.
( 1 1) calculated ORs of 6.0 for women and 5.3 for men who
currently smoked more than one pack daily. In Shanghai,
China, Ji el a!. (24) found similar ORs for men (1.6; 95% CI,
1.1-2.2) and women (1.4; 95% CI, 0.9-2.4) who currently
smoked. Clavel et a!. (25) found no association between smok-
ing and pancreatic cancer in both men and in women. Two other
reports with separate risk estimates for men and women were
based on few cases or combined smokers and ex-smokers
together in the analysis (26, 9). The slightly higher smoking-
related risks in women may be due to an effect of smoking in
the body or tail of the pancreas. Although we had information
on the site of cancer within the pancreas for only half of the
patients, smoking was related to an increased risk for the body,
tail, and pancreatic duct in women but not in men. Additional
studies are needed to confirm this observation.
Our study and the study by Silverman et a!. (23) show that
switching from a nonfilter cigarette to a filter cigarette did not
lower the risk of pancreatic cancer. Cigarette filters reduce the
concentration of inhaled particulate matter containing the car-
cinogenic polycyclic aromatic hydrocarbons. Tobacco smoke
also contains TSNAs (28). The concentration of TSNAs is not
reduced in the smoke of filter cigarettes compared to nonfilter
cigarettes. This suggests that TSNAs are possibly the respon-
sible agents in tobacco that cause pancreatic cancer. Experi-
mental studies have shown that the TSNAs NNK and NNAL
are the only tobacco components known to cause cancer of the
exocrine pancreas in animals (29). Chewing tobacco contains
significant amounts of tobacco-specific nitrosamines (30). El-
evated rates of pancreatic cancer among chewers of smokeless
tobacco have been observed in some populations (3 1 ), and
significant associations were found in case-control (8) and
cohort studies (19). Our data suggest an association with use of
chewing tobacco, although there were few tobacco chewers in
this study. We found a significant increased risk for pipe and
cigar smokers, who have the tendency not to inhale the smoke,
although there was no significant trend with duration of smok-
ing. The increased risk associated with pipes and cigars is
consistent with earlier findings, however (1, 2). The different
forms of tobacco that are associated with pancreatic cancer
suggest that the TSNAs in tobacco smoke can affect the pan-
creas by inhalation into the lungs, absorption through the oral
cavity, or ingestion.
Alternatively, nicotine in cigarette smoke may be involved
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0 146 334 1.0
l-20yrs 6 7 1.8(0.6-5.3)
>20 yrs 10 13 1.6 (0.7-3.7)
Pipes smoked/day
t) 46 334 1.0
1-5 7 10 1.4 (0.5-3.8)
6 9 10 1.4 (0.9-2.2)
Cigar smoking
0 146 334 1.0
1-20 yrs 7 4 3.9(1.2-13.6)
>2t) yrs 8 7 2.2 (0.8-7.3)
Cigars smoked/day
0 146 334 1.0
1-4 8 II 1.4(0.6-3.6)
5 7 1 14.1 (1.7-1 15.7)
“ ORs for pipe and cigar smokers were adjusted for age and education. Baseline
groups include never smokers and long-term ( >20 years) quitters.
in the postinitiation stage of pancreatic cancer. Nicotine in
drinking water slightly increases the incidence of pancreatic
tumors in experimental animal studies (32) and inhibits apop-
tosis in normal and transformed cells caused by tobacco use
(33).
The results from this study should be interpreted within the
confines of case-control biases such as choice of hospital con-
trols, recall bias, and confounders. There may be hospital-
referral patterns that result in selection bias. For example, the
male:female ratio in black subjects was 0.7, compared to 1 .5 for
white subjects. In one of the participating hospitals, 75% of
cases resided in New York or New Jersey, compared to 85% of
controls (P < 0.01 ), although there were no significant case-
control differences in county of residence within states. There
were no case-control differences in state of residency in other
participating centers. Selection bias resulting in an underesti-
mate of the smoking-related relative risks may have resulted
from the inability to obtain smoking information from deceased
or critically ill patients. These patients may have been the
heaviest smokers. However, the smoking-related risks of pan-
creatic cancer in cohort studies (3, 4) are similar to those found
in the current study. It has also been suggested that the prey-
alence of smoking in hospital controls is higher than in the
general population (34). However, studies by our group corn-
paring the smoking prevalence rates in the neighborhoods of the
participating hospitals reveal a higher smoking prevalence rate
than in our hospital control population, showing that exclusion
of control subjects with tobacco-related diseases is a successful
strategy for reducing selection bias (35). In male controls, the
smoking prevalence ranged from 14% in the patients with
sarcomas and I 6% in the patients with skin cancer to 50% in the
patients with spinal and back problems. In female controls, the
groups with the lowest smoking prevalence were arthritic pa-
tients (8.8%) and fracture patients (16%). The highest preva-
lence of smoking was in women admitted for back problems
(27%). Because the etiology ofpancreas cancer remains largely
unknown, our findings could have been confounded by other
possible factors such as dietary fat or other unknown exposures.
It has been suggested previously that carcinogens present
in the bile may explain the predominance of pancreatic cancers
in the head of the pancreas by reflux of bile into the proximal
pancreatic duct or pancreatic arterioles (6, 7). The tobacco-
specific nitrosamines NNK and NNAL are metabolically acti-
vated in the liver and excreted into the bile. NNK metabolites
have been detected and measured in the bile of rats after i.p.
administration of NNK (36). The higher rate of pancreas cancer
in smokers and tobacco chewers and the production of pancre-
atic tumors in laboratory animals after NNK and NNAL ad-
ministration suggest that this compound may be a carcinogen
for the human pancreas (37). However, the epidemiology of
pancreas cancer indicates that tobacco is a relatively weak
pancreas carcinogen.
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